Teva Pharmaceuticals USA Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count recall — FDA D-0129-2019
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Complete FDA and NHTSA recall records dated in 2018, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results…
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
Lack of assurance of sterility: loss of container integrity.
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results…
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis
Defective Container: Repetitive complaints received indicating pump not working.
Kia Motors America (Kia) is recalling certain 2019 Kia Forte vehicles equipped with LED headlights. The headlights may not have been manufactured with the correct low beam aiming. As such,…
Southeast Toyota Distributors, LLC (SET) is recalling certain 2017-2019 Toyota 4Runner vehicles that SET modified to be equipped with a TRD wheel package. The Gross Vehicle Weight Rating…
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
The latest on-site software version may not have been reinstalled at some sites after service activities were performed resulting in images possibly flipped left/right and/or there can be…
Any change made to current ultrasound machine software or hardware upgrades, adding or modifying custom fields, or adding a new Ultrasound Machine, must be tested prior to the use in…
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
Internal components of the Protein S ELISA Antigen Kit (Lot: 3-16-5292) were mislabeled. The Protein S Conjugate Solution is labeled as Substrate, and the Substrate is labeled as Protein S…
The terminals on the plug may become loose and overheat.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.